Diag Human case
 | You can help expand this article with text translated from the corresponding article in Czech. (January 2026) Click [show] for important translation instructions.
|
 | This article needs to be updated. (January 2026) |
The Diag Human case relates to a Liechtenstein-incorporated blood plasma trading company, established by Swiss-Czech entrepreneur Josef Šťáva (born 17 March 1950 in Prague) in the 1980s.[1] The stated aim of the company was to help "currency-deficient Eastern Bloc states acquire modern blood plasma technology".[1] The company received media attention in the 1996, when it filed a lawsuit against the Czech government in Prague Commercial Court, for defamation and unfair competition. The company claimed that the Health Minister had contacted Novo Nordisk, a major business partner of Diag Human, to dissuade the company from doing business with them, which led to the failure of Diag Human's business in the country.[1] The two parties agreed to enter arbitration,[1] and the case became one of the largest cases of commercial litigation in the history of Czech Republic.[2] In 2008, the court found in favour of Diag Human, awarding around $650 million to the company.[1]
References
[edit]- 1 2 3 4 5 Folkman, Ted (19 August 2014). "Case of the day: Diag Human vs. Czech Ministry of Health". Letters Blogatory. Retrieved 29 January 2026.
- ↑ An article from PragueTravelGuide.info.[permanent dead link]
 | This Czech Republic-related article is a stub. You can help Wikipedia by adding missing information. |